If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or the patient information leaflet↗. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard↗. By reporting side effects you can help provide more information on the safety of this medicine.
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard↗ for how to report side effects.
The information provided on this site is intended for general information and education and is not intended to be a substitute for advice provided by your doctor or other qualified healthcare professionals.
Always take your dose as prescribed by your doctor
Learn about how RYBELSUS® can be used as part of your type 2 diabetes management, to help you improve your control of blood sugar levels
Find out more about RYBELSUS®
UK21RYB00202 | November 2021
▼ This medicinal product is subject to
additional monitoring. This will allow quick identification of
new safety information.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed in the
package leaflet. You can also report side effects directly via the
Yellow Card Scheme at www.mhra.gov.uk/yellowcard↗. By reporting side effects you can help provide more
information on the safety of this medicine.
UK21DI00581
| November 2021
© 2021 Novo Nordisk. All rights reserved
